Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buccal dexmedetomidine for neonatal intravenous cannulation sedation
ISRCTN15759273Phase 4Completed
- Sponsor
- Region Uppsala
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in procedural pain (3 arms), sponsored by Region Uppsala. Primary endpoint: N-PASS observational pain score. Started Oct 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
procedural pain
Beyond the preview
Go deeper on ISRCTN15759273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15759273.